Physician profile
Aaron S Bean
NPI 1245568476
$22,762.20
in general payments reported to CMS, 2019-2025
19 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $159 · 2021: $78.65 · 2022: $86.66 · 2023: $16.83 · 2024: $351 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team_makena_llc | $21,283.20 | 2019 | |
| Paragon 28, INC. | $296.35 | 2024-2025 | Smart28, Apex 3d |
| Shockwave Medical, INC | $191.33 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Trilliant Surgical LLC. | $155.44 | 2019 | |
| Smith+Nephew, INC. | $140.35 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $122.95 | 2020-2025 | Gravity Synchfix |
| Wright Medical Technology, INC. | $119.89 | 2019 | |
| Medline Industries Lp | $76.80 | 2019 | |
| Nevro Corp. | $62.37 | 2021-2023 | Senza |
| Abbott Laboratories | $51.70 | 2020 | |
| Linvatec Corporation | $50.06 | 2019 | |
| Integra Lifesciences Corporation | $35.70 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $34.39 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $28.64 | 2025 | |
| Glaxosmithkline, LLC. | $26.38 | 2025 | Nucala |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $23.74 | 2020 | |
| Treace Medical Concepts, INC. | $23.65 | 2025 | |
| Heron Therapeutics, INC. | $21.12 | 2021 | |
| Depuy Synthes Sales INC. | $18.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Bean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.